MEDITEST will participate in the 64th Scientific Days of the SFPM
Since 2020, Meditest has been the exclusive distributor of IBA Dosimetry in France. World-class technological excellence combined with local support.
Since January 2020, MEDITEST has been the exclusive distributor and service partner of IBA Dosimetry in France. Five years of a strategic partnership combining the technological excellence of a global leader in quality assurance with the local support and field expertise of a long-established French company. A look back at a partnership that is now a benchmark in the French radiotherapy community.
IBA Dosimetry has established itself as the global benchmark in quality assurance for radiotherapy and proton therapy . With over 220 employees located in Germany, France, China, and the United States, the company develops integrated solutions recognized by the world's leading healthcare institutions.
IBA Dosimetry's mission is clear: "to protect, improve, and save lives" by advancing quality assurance in the field of radiotherapy. This commitment translates into solutions that combine precision, reliability, and efficiency —three essential pillars for ensuring the safety of patients and healthcare professionals.
IBA Dosimetry is part of the IBA Group, a global medical technology company focused on developing integrated and innovative solutions for cancer diagnosis and treatment . This affiliation gives IBA Dosimetry the financial strength and innovative capabilities that make a difference in a constantly evolving market.
IBA Dosimetry offers a complete range of software and hardware quality assurance solutions :
These solutions are recognized worldwide for their precision, efficiency and reliability , three essential qualities when it comes to ensuring the accuracy of doses delivered to patients in radiotherapy.
On January 23, 2020 , MEDITEST and IBA Dosimetry officially announced their partnership in the French radiotherapy market. This strategic choice for both partners is based on clear complementarity .
On one hand, IBA Dosimetry brings the technological excellence of a world leader, innovative solutions validated by the largest international radiotherapy centers and a capacity for continuous innovation supported by more than 220 experts dedicated to quality assurance.
On the other hand, MEDITEST brings 40 years of expertise in the French market for quality control in medical imaging, an intimate knowledge of French regulatory constraints (ASN, IRSN), close field contact with the medical physicist community and the ability to provide long-term support.
The result: MEDITEST becomes the exclusive distributor and service partner for the entire IBA Dosimetry range in the French market. This exclusivity guarantees French users privileged access to IBA innovations, expanded stock for immediate availability, and local technical support.
Beyond the commercial agreement, this partnership is based on a convergence of values and a common ambition : to improve patient safety and the performance of quality assurance solutions in radiotherapy.
Radiotherapy is a discipline where precision is vital . An error of a few millimeters or a few percent in dose can have dramatic consequences: underdosing, compromising therapeutic efficacy, or overdosing, causing serious side effects on healthy tissue. Quality assurance is not an option; it is an ethical and regulatory obligation.
IBA Dosimetry and MEDITEST share this conviction: the best technologies must be accessible , mastered and supported to fully deploy their potential for patient protection.
As the exclusive distributor, MEDITEST benefits from privileged access to IBA innovations before their release on the French market. This translates into:
Result: you gain access to the latest IBA innovations with immediate operational support , without any availability delays or skills development time.
Meditest maintains a permanent stock of the entire IBA Dosimetry range, equivalent to several weeks of sales. This proactive stock policy guarantees:
In practice
Do you need an ionization chamber for an urgent quality control inspection? Order today, receive it tomorrow. No French facility should have to postpone a regulatory inspection due to delivery delays.
Distributing the world's best technologies is not enough if users do not fully master their potential. That's why Meditest places training at the heart of the IBA partnership .
Initial enhanced training
For each IBA equipment installation, Meditest provides comprehensive user training :
Continuous technical support
Beyond initial training, Meditest provides ongoing technical support :
Meditest provides local after-sales service for the entire IBA Dosimetry range:
The goal: to offer you the responsiveness of a local partner with the expertise of a global leader .
Since 2020, Meditest has equipped hundreds of radiotherapy facilities across France with IBA Dosimetry solutions. These facilities cover the entire spectrum of establishments:
This diversity of installations demonstrates the versatility of IBA solutions and Meditest ability to support all types of configurations, from the most standard to the most sophisticated.
Beyond the figures, this partnership has made it possible to build a lasting relationship of trust with French medical physicists, medical radiographers and biomedical engineers.
This trust rests on three pillars:
1. The reliability of IBA solutions
Recognized worldwide for their precision and robustness, IBA Dosimetry solutions offer indispensable peace of mind in an environment where error is not acceptable.
2. Meditest responsiveness
Availability, attentiveness, and the ability to resolve problems quickly. Proximity makes all the difference in critical situations.
3. Shared expertise
Meditest and IBA do not just sell equipment: we share our expertise, train teams and contribute to the skills development of the entire French community.
Radiotherapy is undergoing an accelerated digital transformation : artificial intelligence for autosegmentation, predictive analysis of dose distributions, cloud platform to centralize multi-site quality assurance.
IBA Dosimetry is at the forefront of this transformation with the myQA Global QA platform , a true digital backbone that enables:
Meditest supports this transformation by training teams in these new uses and providing technical support on these cloud platforms.
In 2025, Meditest reaffirms its strong commitment to IBA Dosimetry and the French radiotherapy community. This commitment is reflected in:
The objective remains unchanged since 2020: to ensure that every French medical physicist, technician, and biomedical engineer has the best quality assurance solutions in the world , with the close support they deserve.
Whether you are in the planning phase for equipping a new center , renewing existing equipment , or simply looking to optimize your quality assurance practices , our teams are at your disposal.
Our 4-step support program
1. Audit of your needs
Analysis of your configuration, regulatory constraints, and current workflows. Proposal of a suitable IBA solution.
2. Demonstration and training
Presentation of solutions, training of your teams, validation of the proposed protocols.
3. Installation and commissioning
Delivery, installation, configuration, in-depth user training, metrological validation.
4. Long-term support
Ongoing technical support, preventative maintenance, software upgrades, and continuous training.
Since January 2020, the partnership between IBA Dosimetry and Meditest has proven its strength and relevance. Hundreds of facilities equipped, thousands of patients protected, and a community of medical physicists supported on a daily basis.
In 2025, this partnership will be further strengthened to meet the growing challenges of modern radiotherapy: increased precision, digitalization, workflow optimization, and enhanced regulatory compliance.
Do you have a quality assurance project in radiotherapy? Our teams are available to support you with IBA excellence and Meditest proximity.
These articles might also interest you.
Since 2020, Meditest has been the exclusive distributor of IBA Dosimetry in France. World-class technological excellence combined with local support.
New CEO, new vision. Thibaut Baudson is structuring Meditest 's future around three strategic pillars. Discover our 2027 ambition.
Since 2020, Meditest has been the exclusive distributor of IBA Dosimetry in France. World-class technological excellence combined with local support.
Request a quote
To learn about and exercise your rights, including withdrawing your consent to the use of data collected by this form, please consult our privacy policy.